Alzheimer’s disease (AD) |
extracellular Aβ amyloid plaques and intracellular hyperphosphorylated τ-protein neurofibrillary tangles; cholinergic neuron loss; neurodegenerative |
[9] |
Parkinson’s disease (PD) |
intracellular aggregates of α-synuclein; dopaminergic neuron loss in substantia nigra pars compacta; neurodegenerative |
[10] |
Huntington’s disease(HD) |
aggregates of misfolded huntingtin; shrinkage of brain; neuron loss in striatum; neurodegenerative |
[11] |
Multiple sclerosis (MS) |
auto-immune-mediated demyelination of neurons; neurodegenerative |
[12] |
Depression |
dysregulated neuroplasticity monoamine neurotransmission; neuroendocrinal function |
[13] |
Anxiety disorders |
disturbances of neurotransmittency |
[14] |
Schizophrenia |
disturbances of neurotransmittency; altered connectivity and neuroplasticity in neurodevelopmental period |
[15] |
Ischemic stroke |
occlusion of cerebral artery, e.g., by thrombus with subsequent regional decrease of oxygen to the brain; |
[16] |
Infections |
bacteria (e.g., Escherichia coli, Neisseria meningitidis); viruses (e.g., Ebola virus, HIV); protozoa and helminths (e.g., Toxoplasma gondii); fungi (e.g., Cryptococcus neoformans) |
[17] |
CNS cancer |
gene alteration; oxidative damage; environmental causes (e.g., diet); infections |
[18] |